Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Smoking Cessation 1Motor Activity 1Inflammation 1Fatigue 1Endometrial Neoplasms 1Colonic Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Modafinil 9Methylphenidate 4Saline Solution 3regorafenib 2Sugars 2Physical Therapy Modalities 2Exercise 2Dexamethasone 2reparixin 1ofatumumab 1epoetin beta 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1clazakizumab 1caffeine, sodium benzoate drug combination 1Yoga 1Walking 1Waiting Lists 1Vinorelbine 1Urinalysis 1Therapeutics 1Thalidomide 1Testosterone 1Sodium Chloride 1Proton Pump Inhibitors 1Patient Reported Outcome Measures 1Megestrol Acetate 1Lenalidomide 1Lactose 1Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fatigue × Hematologic Tests × Clear all
NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Clinical Research Support Center Kyush

Phase 2 Unknown
74 enrolled
Gastrointestinal

Fatigue, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡